HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PWUP

PowerUp Acquisition Corp

Last Close
Dec 11 • 11:38AM ET
11.44
Dollar change
-0.12
Percentage change
-1.07 		%
Financial • Shell Companies • USA • NASD
Held by: SPAX
Scroll to Statements
Index- P/E- EPS (ttm)-0.43 Insider Own92.56% Shs Outstand7.77M Perf Week-1.33%
Market Cap88.87M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.58M Perf Month-4.60%
Income-3.76M PEG- EPS next Q- Inst Own5.95% Short Float0.39% Perf Quarter0.60%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio0.84 Perf Half Y5.13%
Book/sh0.01 P/B983.49 EPS next Y- ROA-28.30% Short Interest0.00M Perf Year9.35%
Cash/sh0.00 P/C- EPS next 5Y- ROE-38.21% 52W Range10.84 - 14.47 Perf YTD5.03%
Dividend Est.- P/FCF- EPS past 5Y- ROI-4161.59% 52W High-20.95% Beta0.02
Dividend TTM- Quick Ratio0.01 Sales past 5Y0.00% Gross Margin- 52W Low5.52% ATR (14)0.39
Dividend Ex-Date- Current Ratio0.01 EPS Y/Y TTM-325.44% Oper. Margin- RSI (14)46.84 Volatility0.00% 4.23%
Employees2 Debt/Eq59.33 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-798.70% Payout0.00% Rel Volume0.00 Prev Close11.56
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume2.67K Price11.44
SMA20-1.73% SMA50-1.22% SMA2002.63% Trades Volume1 Change-1.07%
Sep-03-24 08:01AM
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
(GlobeNewswire)
Jul-31-24 08:01AM
Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.
(GlobeNewswire)
Jun-05-24 04:05PM
PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
(GlobeNewswire)
May-20-24 05:11PM
PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders
(GlobeNewswire)
May-16-24 04:05PM
PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders
(GlobeNewswire) +7.62%
08:01AM Loading…
Jan-29-24 08:01AM
PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination
(GlobeNewswire)
Dec-27-23 08:01AM
Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.
(GlobeNewswire)
PowerUp Acquisition Corp. is a blank check company. Its objective is effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.